LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 76.94 | 17.25 | 4433 | 5681 | 0.7802 | 0.9415 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 78.91 | 17.25 | 4 | 5730 | 0.0007 | -0.1601 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 78.91 | 17.25 | 4343 | 5730 | 0.7579 | 0.9349 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 78.91 | 17.25 | 4 | 5730 | 0.0007 | -0.1601 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 78.91 | 17.25 | 4576 | 5730 | 0.7985 | 0.9470 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 80.88 | 17.25 | 4 | 5826 | 0.0007 | -0.1597 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 80.88 | 17.25 | 4440 | 5826 | 0.7621 | 0.9363 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 80.88 | 17.25 | 12 | 5826 | 0.0021 | -0.0423 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 80.88 | 17.25 | 4743 | 5826 | 0.8141 | 0.9516 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 82.85 | 17.25 | 3 | 5861 | 0.0005 | -0.1878 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 82.85 | 17.25 | 4558 | 5861 | 0.7776 | 0.9411 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 82.85 | 17.25 | 18 | 5861 | 0.0031 | 0.0051 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 82.85 | 17.25 | 4879 | 5861 | 0.8324 | 0.9568 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 84.82 | 17.25 | 3 | 5924 | 0.0005 | -0.1875 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 84.82 | 17.25 | 4683 | 5924 | 0.7905 | 0.9450 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 84.82 | 17.25 | 13 | 5924 | 0.0022 | -0.0330 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 84.82 | 17.25 | 5024 | 5924 | 0.8481 | 0.9613 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 86.79 | 17.25 | 1 | 6008 | 0.0002 | -0.2863 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 86.79 | 17.25 | 4867 | 6008 | 0.8101 | 0.9507 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 86.79 | 17.25 | 3 | 6008 | 0.0005 | -0.1871 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 86.79 | 17.25 | 5116 | 6008 | 0.8515 | 0.9623 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 88.76 | 17.25 | 1 | 6047 | 0.0002 | -0.2860 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 88.76 | 17.25 | 5052 | 6047 | 0.8353 | 0.9579 | MN20160310_N02 | F13 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 88.76 | 17.25 | 6 | 6047 | 0.0010 | -0.1175 | MN20160310_N02 | L16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 88.76 | 17.25 | 5246 | 6047 | 0.8674 | 0.9666 | MN20160310_N02 | L16 |